“The ERT PRO / eCOA Congress is the only U.S. event dedicated to providing case studies and pragmatic information on the clinical science, regulatory and innovative technologies used to collect patient data for clinical studies.”
Philadelphia, PA (PRWEB) August 17, 2015
ERT, a leading global provider of high-quality patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions has opened registration for its Annual U.S. Congress focused on the collection of Patient Reported Outcomes (PRO) and electronic Clinical Outcome Assessment (eCOA) data in clinical research. The Congress takes place October 27-29, 2015 in Washington, DC. Complete Congress information, including agenda, faculty, and registration can be found here.
The U.S. PRO / eCOA Congress is the 8th installment of the ERT educational series, which includes events across the U.S., Europe and Japan. The European PRO & eCOA Congress, which takes place September 22-24, 2015 in Lisbon, Portugal is also accepting registrations here.
Each ERT Congress event is designed to provide attendees with actionable insights on effectively implementing PRO and eCOA strategies for endpoint data collection. An esteemed faculty comprised of leading pharmaceutical and industry experts will lead interactive discussions on current, practical topics pertaining to the collection of patient-centric data, wearables in clinical development, eSource, BYOD, centralized rater performance monitoring and global regulatory trends. Confirmed speakers to date include:
- Johnathan Helfgott, Director of Regulatory Affairs at Stage 2 Innovations, and former Associate Director for Risk Science, Intelligence, & Prioritization, U.S. FDA CDER will present “Wearables and Objective Measurement: What’s the Secret?”
- Cancer Survivor and Legislative Advocate Jack Whelan will present his personal and oft- humorous bumpy ride on the road to Personalized Medicine with “Innovations in Clinical Trials to Improve the Patient Experience: Case Study & Innovations in Beta Testing"
- Susan M. Dallabrida, PhD, Vice President, eCOA Clinical Science and Consulting, ERT will present “Disruptive Innovation: ERT 3-in-1 Rater Training for Clinicians, Caregivers, Subjects and Site Staff– on Study Device”
“The ERT PRO / eCOA Congress is the only U.S. event dedicated to providing case studies and pragmatic information on the clinical science, regulatory and innovative technologies used to collect patient data for clinical studies,” said Christine Hall, Director eCOA Product and Clinical Science Marketing at ERT. “At the end of this two day event, attendees will have met and engaged with the leading eCOA community and garnered new tools and methodologies that will enable them to effectively implement eCOA initiatives.”
For more information and to register for the European and US Congress, please visit https://www.ert.com/events/.
ERT (http://www.ert.com) is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process throughout the product lifecycle. ERT delivers the most widely deployed solutions in centralized Cardiac Safety, Respiratory, Suicide Risk Assessment, electronic Clinical Outcome Assessments (eCOA) – which includes patient-, clinician-, observer- and performance-reported outcomes – and cloud-based analytics and performance metrics. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products. ERT is a global organization with headquarters in Philadelphia, PA and offices throughout the U.S., U.K., Switzerland, Japan and Germany.